Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2026-04-22 16:40:35 ET · period of report 2026-04-21 · accession 0001437749-26-013041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-04-22 16:40 | 2026-04-21 | ETON | RIEDEL NORBERT G | Dir | M - OptEx | $8.10 | +32.2K | 67.2K | +92% | +$260.6K |
| DM | 2026-04-22 16:40 | 2026-04-21 | ETON | RIEDEL NORBERT G | Dir | M - OptEx | $0.00 | -32.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-21 | M | A | 12,500 | $7.31 | 47,500 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-21 | M | A | 19,655 | $8.61 | 67,155 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-04-21 | M | D | 12,500 | $0.00 | 0 | D | $7.31 · 2020-02-20 to 2029-02-19 | 12,500 Common Stock | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2026-04-21 | M | D | 19,655 | $0.00 | 0 | D | $8.61 · 2022-05-03 to 2031-05-02 | 19,655 Common Stock |